Superstring Capital Management as of Dec. 31, 2024
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 38 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oric Pharmaceuticals Call Option (ORIC) | 12.4 | $14M | 1.8M | 8.07 | |
| Terns Pharmaceuticals (TERN) | 9.7 | $11M | 2.0M | 5.54 | |
| Zai Lab Adr (ZLAB) | 9.2 | $11M | 404k | 26.19 | |
| Novocure Ord Shs (NVCR) | 7.4 | $8.6M | 287k | 29.80 | |
| Bridgebio Pharma (BBIO) | 6.2 | $7.2M | 262k | 27.44 | |
| Cogent Biosciences (COGT) | 6.2 | $7.1M | 911k | 7.80 | |
| Cytokinetics Com New (CYTK) | 5.3 | $6.1M | 129k | 47.04 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 5.1 | $5.9M | 217k | 27.12 | |
| Ideaya Biosciences (IDYA) | 5.1 | $5.8M | 227k | 25.70 | |
| Urogen Pharma (URGN) | 2.8 | $3.2M | 301k | 10.65 | |
| Summit Therapeutics (SMMT) | 2.5 | $2.9M | 165k | 17.84 | |
| Instil Bio Com New (TIL) | 2.4 | $2.8M | 148k | 19.09 | |
| Protagonist Therapeutics (PTGX) | 2.3 | $2.7M | 69k | 38.60 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $2.5M | 36k | 69.04 | |
| Fate Therapeutics (FATE) | 2.0 | $2.3M | 1.4M | 1.65 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.0 | $2.3M | 70k | 32.54 | |
| Protara Therapeutics Com Stk (TARA) | 1.6 | $1.9M | 360k | 5.28 | |
| Cabaletta Bio (CABA) | 1.6 | $1.9M | 822k | 2.27 | |
| Dyne Therapeutics (DYN) | 1.5 | $1.7M | 73k | 23.56 | |
| Savara (SVRA) | 1.4 | $1.6M | 508k | 3.07 | |
| Tango Therapeutics (TNGX) | 1.3 | $1.5M | 475k | 3.09 | |
| Kura Oncology (KURA) | 1.2 | $1.4M | 158k | 8.71 | |
| Incyte Corporation (INCY) | 1.1 | $1.2M | 18k | 69.07 | |
| Beigene Sponsored Adr (ONC) | 1.0 | $1.2M | 6.4k | 184.71 | |
| Verastem Com New (VSTM) | 0.9 | $1.1M | 210k | 5.17 | |
| 89bio (ETNB) | 0.9 | $1.0M | 133k | 7.82 | |
| Zenas Biopharma (ZBIO) | 0.8 | $914k | 112k | 8.19 | |
| Capricor Therapeutics Com New (CAPR) | 0.7 | $762k | 55k | 13.80 | |
| Kyverna Therapeutics (KYTX) | 0.6 | $681k | 182k | 3.74 | |
| Rezolute Com New (RZLT) | 0.5 | $604k | 123k | 4.90 | |
| Century Therapeutics (IPSC) | 0.4 | $468k | 463k | 1.01 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $467k | 187k | 2.50 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $368k | 49k | 7.45 | |
| Axsome Therapeutics (AXSM) | 0.3 | $361k | 4.3k | 84.61 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $348k | 1.1k | 308.57 | |
| Lexeo Therapeutics (LXEO) | 0.3 | $346k | 53k | 6.58 | |
| Eliem Therapeutics (CLYM) | 0.2 | $177k | 98k | 1.80 | |
| Lakeshore Biopharma Ord Shs New (LSBCF) | 0.1 | $106k | 31k | 3.45 |
